Growth Metrics

Biogen (BIIB) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Biogen (BIIB) over the last 8 years, with Q4 2025 value amounting to $68.0 million.

  • Biogen's Depreciation and Depletion fell 659.34% to $68.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $272.8 million, marking a year-over-year decrease of 484.83%. This contributed to the annual value of $272.8 million for FY2025, which is 484.83% down from last year.
  • Latest data reveals that Biogen reported Depreciation and Depletion of $68.0 million as of Q4 2025, which was down 659.34% from $66.5 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Depreciation and Depletion registered a high of $76.3 million during Q1 2022, and its lowest value of $48.8 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $66.6 million (2021), whereas its average is $66.1 million.
  • Per our database at Business Quant, Biogen's Depreciation and Depletion surged by 5635.25% in 2022 and then crashed by 1861.07% in 2023.
  • Quarter analysis of 5 years shows Biogen's Depreciation and Depletion stood at $66.6 million in 2021, then dropped by 2.85% to $64.7 million in 2022, then dropped by 1.85% to $63.5 million in 2023, then rose by 14.65% to $72.8 million in 2024, then dropped by 6.59% to $68.0 million in 2025.
  • Its last three reported values are $68.0 million in Q4 2025, $66.5 million for Q3 2025, and $66.9 million during Q2 2025.